Refine Search
(3)
(5)
(10)
(11)

Hyperoxaluria - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperoxaluria - Pipeline Review, H2 2016’, provides an overview of the Hyperoxaluria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperoxaluria, com...

Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016’, provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) pipeline landscape.

The report provides comprehensive information on t...

Nephrotic Syndrome - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nephrotic Syndrome - Pipeline Review, H1 2018’, provides an overview of the Nephrotic Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nephroti...

Glomerulonephritis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glomerulonephritis - Pipeline Review, H2 2018’, provides an overview of the Glomerulonephritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Glomerul...

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018’, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape.

The report provides comprehensive inform...

Overactive Bladder - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H2 2018’, provides an overview of the Overactive Bladder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Overacti...

Kidney Fibrosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H2 2018’, provides an overview of the Kidney Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Kidney Fibrosi...

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018’, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline landscape.

The report provi...

Nocturia - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nocturia - Pipeline Review, H1 2019’, provides an overview of the Nocturia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nocturia, complete with anal...

Urinary Incontinence - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H1 2019’, provides an overview of the Urinary Incontinence pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Urin...

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape.

The report provides comprehensive info...

Primary Hyperoxaluria - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Hyperoxaluria - Pipeline Review, H1 2019’, provides an overview of the Primary Hyperoxaluria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pr...

Contrast Induced Nephropathy - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Contrast Induced Nephropathy - Pipeline Review, H1 2019’, provides an overview of the Contrast Induced Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...